Iconovo (ICO) - Total Liabilities
Based on the latest financial reports, Iconovo (ICO) has total liabilities worth Skr13.16 Million SEK (≈ $1.42 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Iconovo operating cash flow efficiency to assess how effectively this company generates cash.
Iconovo - Total Liabilities Trend (2015–2025)
This chart illustrates how Iconovo's total liabilities have evolved over time, based on quarterly financial data. Check ICO financial resilience to evaluate the company's liquid asset resilience ratio.
Iconovo Competitors by Total Liabilities
The table below lists competitors of Iconovo ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Canadian Premium Sand Inc
V:CPS
|
Canada | CA$5.09 Million |
|
Sonoro Energy Ltd
V:SNV
|
Canada | CA$1.26 Million |
|
Commerce Split Corp
TO:YCM
|
Canada | CA$9.04 Million |
|
COINSILIUM GROUP LTD
F:5CT
|
Germany | €347.64K |
|
FD Technologies Plc
LSE:FDP
|
UK | GBX149.47 Million |
|
Tapaco Public Company Limited
BK:TAPAC
|
Thailand | ฿942.67 Million |
|
Cambridge Technology Enterprises Limited
NSE:CTE
|
India | Rs1.13 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Iconovo's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ICO stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Iconovo's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Iconovo (2015–2025)
The table below shows the annual total liabilities of Iconovo from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr13.16 Million ≈ $1.42 Million |
-20.10% |
| 2024-12-31 | Skr16.47 Million ≈ $1.77 Million |
+13.19% |
| 2023-12-31 | Skr14.55 Million ≈ $1.57 Million |
-54.48% |
| 2022-12-31 | Skr31.97 Million ≈ $3.44 Million |
+177.80% |
| 2021-12-31 | Skr11.51 Million ≈ $1.24 Million |
+38.41% |
| 2020-12-31 | Skr8.32 Million ≈ $894.85K |
+67.69% |
| 2019-12-31 | Skr4.96 Million ≈ $533.64K |
-43.11% |
| 2018-12-31 | Skr8.72 Million ≈ $937.94K |
-17.57% |
| 2017-12-31 | Skr10.57 Million ≈ $1.14 Million |
-7.06% |
| 2016-12-31 | Skr11.38 Million ≈ $1.22 Million |
+118.88% |
| 2015-12-31 | Skr5.20 Million ≈ $559.38K |
-- |
About Iconovo
Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more